R.I. biotech companies share $4.6 million in grants for health care therapies
PROVIDENCE – Fourteen Rhode Island companies will share $4.6 million in federal grants to develop new and cost-saving health care therapies, two federal agencies announced Wednesday.

Read more on Providence Business News

Lentigen awarded $1.23M grant under Patient Protection and Affordable Care Act
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that it will receive $1,235,306 in cash grants from the U.S. Government under the Patient Protection and Affordable Care Act.

Read more on News-Medical-Net

Valley startups aim to improve the health of the health care system
Valley companies look to streamline patient records for doctors and hospitals.

Read more on San Jose Mercury News

In a presentation entitled: Systems Medicine and Emerging Technologies: Catalyzing a Transformation from a Reactive to a Proactive (P4) Medicine (predictive, personalized, preventive and participatory), Dr Hood outlines the Systems Biology Institutes ultimate goal of enhancing peoples lives by using the science of systems biology to predict, prevent, and cure disease. As the ability to garner huge amounts of data about our bodies and the environment becomes cheaper and more commonplace, this may become the new basis for medical care. Learn why the SCImago Group rated the Institute for Systems Biologys papers as having the most scientific impact in the USA and third highest worldwide. A Montana native and recipient of both the Lasker and Kyoto prizes, Dr. Hood has 17 honorary degrees (including one from MSU). He also holds a George R. Stibitz award from the Bozeman American Computer Museum, and has founded 14 biotechnology companies.